XNAS: ZNTL
Zentalis Pharma Inc Live Stock Price Today, Share Analysis and Chart
about
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1...
Read More
4.04
-0.05
(-1.22%)
714.6K
XNAS Volume
XNAS 04 May, 2026 3:33 PM (EDT)
Board Meeting
The next board meeting for Zentalis Pharma Inc is on 14 May 2026 for the purpose of Zentalis Pharmaceuticals Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bullish
Zentalis Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..